Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 3, 2004, Pages 352-360

  Githui, W A ^b   Jordaan, A M ^a   Juma, E S ^b   Kinyanjui, P ^b   Karimi, F G ^b   Kimwomi, J ^b   Meme, H ^b   Mumbi, P ^b   Streicher, E M ^a   Warren, R ^a   Van Helden, P D ^a   Victor, Tommie C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Beijing W genotypes; Drug resistance; Kenya; MDR TB; Nairobi

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DNA SEQUENCE; DOT HYBRIDIZATION; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; KENYA; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; KENYA; MALE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RIBOTYPING; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 2442596241     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family [see comments]. JAMA 1996; 275: 452-457.
2. Breathnach A S, de Ruiter A, Holdsworth G M, et al. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998; 39: 111-117.
3. Coronado V G, Beck-Sague C M, Hutton M D, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993. 168: 1052-1055.
4. Portugal I, Covas M J, Brum L, et al. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 1999; 3: 207-213.
5. Valway S E, Richards S B, Kovacovich J, Greifinger R B, Crawford J T, Dooley S W. Outbreak of multidrug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol 1994; 140: 113-122.
6. van Rie A, Warren R M, Beyers N, et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling 'strain W' among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis 1999: 180: 1608-1615.
7. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Anti-tuberculosis drug resistance in the world. WHO/TB/97.229. Geneva, Switzerland: WHO, 1997.
8. Pablos-Mendez A, Raviglione M C, Lazlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998: 338: 1641-1649.
9. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. WHO/CDS/TB/2000.278. Geneva, Switzerland: WHO, 2000.
10. Dye C, Espinal M A, Watt C J, Mbiaga C, Williams B G. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2000; 185: 1197-1202.
11. Davies G R, Pillay M, Sturm, A W, Wilkinson D. Emergence of multidrug-resistance tuberculosis in a community-based directly observed treatment programme in rural South Africa. Int J Tuberc Lung Dis 1999; 3: 799-804.
12. Schaaf H S, Van Rie A, Gie R P, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J 2000; 19: 695-699.
13. Bretzel G, Aziz M, Wendl-Richter U, et al. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Int J Tuberc Lung Dis 1999; 3: 810-815.
14. Githui W A, Juma E S, van Gorkom J, Kibuga D, Odhiambo J, Drobnewski F. Antituberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis 1998; 2: 499-505.
15. Githui W A, Hawken M P, Juma E S, et al. Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis 2000; 4: 947-955.
16. Victor T C, van Helden P D, Warren R. Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life 2002; 53: 231-237.
17. Victor T C, Jordaan A M, van Rie A, et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tubercle Lung Dis 1999; 79: 343-348.
18. van Rie A, Warren R, Mshanga I, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001; 39: 636-641.
19. Frieden T R, Woodley C L, Crawford J T, Lew D, Dooley S M. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tubercle Lung Dis 1996; 77: 407-413.
20. Bifani P J, Mathema B, Kaurepina N E, Kreiswirth B N. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002; 10: 45-52.
21. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914.
22. Glynn J R, Whiteley J, Bifani P J, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-849.
23. Sola C, Filliol I, Gutierrez M C, Mokrousov I, Vincent V, Rastogi N. Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg Infect Dis 2001; 7: 390-396.
24. Filliol I, Driscoll J R, van Soolingen D, et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis 2002; 8: 1347-1349.
25. Cannetti G, Fox W, Khomenko A, Mahler N, Mitchison D, Rist Smelev N. Advances in techniques of testing mycobacterial drug sensitivity and the use of mycobacterial drug sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
26. Kenya/British Medical Research Council co-operative investigations. Tuberculosis in Kenya. A 3rd National Sampling Survey of drug resistance and other factors and comparison with the 1st two National Surveys. Tubercle 1989; 70: 5-20.
27. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global Working Group on Antituberculosis Drug Resistance Surveillance. Guidelines for Surveillance of drug resistance in tuberculosis. WHO/TB/96.216. Geneva, Switzerland: WHO, 1997.
28. Hermans P W, van Soolingen D, Dale J W, et al. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J Clin Microbiol 1990; 28: 2051-2058.
29. Ramaswamy S, Musser J M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle Lung Dis 1998; 79: 3-29.
30. Ramaswamy S V, Amin A G, Goksel S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 326-336.